addition, NO availability 11 or Cx-nitrosylation 12 are enzymatically controlled in the vicinity of MEGJ. Indeed, experiments in different cell types including vascular cells clearly demonstrate that NO can divergently modulate gap junctional intercellular communication (GJIC) depending on the expression of individual connexins. [12] [13] [14] [15] We have shown before that Cx37 is not only critical for the control of intercellular gap junctional calcium signal spread but also highly expressed in MEGJ of small resistance arteries. 15 We have also shown, in accordance with others, that NO can inhibit Cx37-dependent gap junctional molecule transfer, [14] [15] [16] but the underlying modification of Cx37 by NO has not been elucidated yet. In the present study, we aimed to identify the molecular mechanism by which NO reduces the spread of the calcium signal via Cx37-containing GJ. We hypothesized that NO may interfere with the phosphorylation of a specific site in the C-terminus of Cx37 and that NO, by inhibiting endothelial calcium loss via MEGJ, would be able to modulate the calcium signal within microvascular endothelial cells (EC) on stimulation.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Cx37 Fused to Green Fluorescent Protein Forms Functional Intact GJ Sensitive to NO
A full-length construct of Cx37 fused to GFP (green fluorescent protein) at its C-terminus was expressed in Cx-deficient HeLa cells (cervical cancer cell line). The stably transfected HeLa cells (HeLa Cx37-GFP) showed the typical dot-like distribution of Cx37 at cell borders, but Cx37 was also localized within the cytosol ( Figure 1A) . A local calcium increase within a single cell was induced by mechanical stimulation. In cells expressing Cx37, but not in connexin-deficient control cells, this calcium signal spread with some delay to adjacent and further on to secondary adjacent cells as defined before 15 ( Figure 1B ). The spread of calcium signals across cells expressing HeLa Cx37-GFP was similar, as observed before in HeLa cells expressing Cx37 without GFP. 15 The spread of calcium signals via GJ could be inhibited by reducing the pH of the bath solution from pH 7.4 (100±11%) to pH 6.6 (63±6%; Figure 1C ). The reduction of extracellular pH did neither reduce the basal calcium signal nor the amplitude of the calcium increase within the initially stimulated cells (Figures I and II in the online-only Data Supplement). Likewise, pre-exposure to the NO donor S-nitroso-Nacetyl-d,l-penicillamine (SNAP) significantly reduced the spread of calcium signals to adjacent cells. Dose-response studies with SNAP yielded a 50% inhibition at a concentration of 2 µmol/L ( Figure 1D and 1E ). This concentration was used in all further experiments. Neither the basal calcium nor the mechanically induced calcium increases in the initially stimulated cells were significantly altered in the presence of NO (Figures I and II in the online-only Data Supplement). Again, this result was comparable with previously obtained data in cells expressing Cx37 without GFP. 15 Additionally, control experiments revealed that NO had no acute effect on the calcium level in cultured cells (Δ calcium: 0.009±0.002; n=3). Furthermore, ionomycin induced a calcium increase in all cells of the tested cultures (HeLa-Cx37-GFP, HeLa del319, and HeLa Y332A; n=3 each), and the magnitude of the increase was independent of pH changes in the buffer solution from pH 7.4 to pH 6.6 (Cx37-GFP: pH 7.4: 0.26±0.15, pH 6.6: 0.21±0.11; Del319: pH 7.4: 0.18±0.07, pH 6.6: 0.17±0.10; and Y332A: pH 7.4: 0.17±0.11, pH 6.6: 0.18±0.10; n=3 each).
We further analyzed whether exposure to SNAP affected the intracellular movement of GFP-tagged Cx37 spots, which were tracked in cells with and without NO exposure. The movement velocity of Cx37-GFP was not significantly different between both conditions (control [con]: 118±6 nm/s; NO: 123±9 nm/s; n=8) and also not different from the velocity of Cx37-GFP mutants (del319-GFP: con: 128±4 nm/s, NO: 124±6 nm/s and Y332A-GFP: con: 113±15 nm/s, NO: 117±14 nm/s; n=8).
The C-Terminal Part of Cx37 Is Essential for the NO Effect
To identify which part of the C-terminal region of Cx37 is responsible for the NO effect, a deletion mutant lacking the last 14 C-terminal amino acids (del319-GFP) was expressed in Cx-deficient HeLa cells. Del319-GFP showed a similar subcellular distribution of Cx37 as Cx37-GFP (Figure 2A ). This mutant formed functional GJ as assessed by the intercellular spread of calcium signals. In contrast to cells expressing full-length Cx37, the inhibitory effect of NO on gap junctional calcium signal propagation was completely abolished (Figure 2A ). Likewise, a mutant in which the only tyrosine within the last 14 C-terminal amino acids (at position 332) was exchanged to alanine (Y332A-GFP) showed no altered distribution and was still able to form functional GJ. However, the inhibitory effect of NO was again abolished ( Figure 2B ). In both mutants, however, the inhibitory effects of extracellular acidosis were fully preserved.
NO Prevents Dephosphorylation of Y332
In further experiments, we studied whether NO affected the phosphorylation state of C-terminal tyrosine 332. To this end, we analyzed a peptide representing the last 10 C-terminal amino acids of Cx37 containing a phosphorylated tyrosine at a position analogous to Y332 (Cx37-phosphopeptide; Figure 3A ). Control mass spectra yielded signals representing the mass of the unmodified peptide ( Figure 3B and 3C, arrows) and peaks indicating the presence of the tyrosinephosphorylated form of the Cx37 peptide ( Figure 3B and 3C, black arrows). A significant reduction of phosphorylation was observed after incubation with control lysates of cells pretreated with HEPES buffer ( Figure 3B ). In contrast, incubation with lysates from cells pretreated with HEPES buffer containing NO (SNAP, 2 µmol/L; 15 minutes) partially prevented the tyrosine dephosphorylation as indicated by the higher intensity of signals of phosphorylated peptide ( Figure 3C , black arrows). The intensity of the ratio dephosphorylated/ phosphorylated peptide was significantly lower after pretreatment with NO ( Figure 3D ; con: 1.03±0.18; NO: 0.55±0.05).
In contrast, lysates of NO-treated cells did not modify the mass spectra of peptides containing nonphosphorylated tyrosine (sum of phosphorylated peaks/sum of dephosphorylated peaks: con: 0.04±0.01; NO: 0.06±0.02; n=9). To study whether this mechanism is also operative in EC, we used primary human umbilical vein EC (HUVEC). HUVEC lysates exerted similar effects as HeLa cell lysates because they also reduced the phosphorylation of the peptide. Again, pretreatment with NO significantly inhibited the dephosphorylation of the tyrosine residue ( Figure 3E ; con: ratio of dephosphorylated/phosphorylated con=0.46±0.13; ratio of dephosphorylated/phosphorylated NO: 0.09±0.03).
Tyrosine Phosphatase Dephosphorylates Cx37
In view of the inhibitory effect of NO on Y332 dephosphorylation, we studied a potential involvement of tyrosine phosphatases. Indeed, preincubation of the cells with the tyrosine phosphatase inhibitor orthovanadate (0.5 mmol/L) prevented the dephosphorylation of the Cx37-phosphopeptide. However, the combined pretreatment with orthovanadate and NO had no further inhibitory effect (orthovanadate: 0.60±0.10; orthovanadate+NO: 0.61±0.10; Figure 3D ). SHP-1 and SHP-2 are tyrosine phosphatases that are known to be regulated by NO.
17,18 SHP-2 was found to be homogenously distributed within HeLa cells, whereas SHP-1 was exclusively detected in their nuclei ( Figure 4A 
NO Reduces GJIC by Inhibition of SHP-2-Mediated Tyrosine Dephosphorylation of Cx37 at Position 332
To further analyze the role of SHP-2 for the gap junctional spread of the calcium signal, we studied HUVEC overexpressing either wild-type SHP-2 (WT) or a constitutively active (E76A) or an inactive (CS) form of SHP-2. To exclude potential compensatory effects of Cx43 15 for the calcium transfer in EC, its expression was knocked down by a specific siRNA. 15 Mechanical stimulation of a single cell in a monolayer of HUVEC expressing WT SHP-2 led to a GJ-dependent spread of calcium signals to directly adjacent and to secondary adjacent cells. This spread was significantly reduced by ≈35% because of NO treatment. Expression of inactive SHP-2 (CS) reduced the calcium signal spread to the same amount as NO treatment of WT SHP-2 cells (CS con: 57±7%; Figure 5A ). The additional treatment with NO had no further effect (CS NO: 61±10%; Figure 5A ), indicating that SHP-2 inhibition is responsible for the NO effect. Expression of SHP-2 E76A led to a GJ-dependent spread of calcium signals comparable to WT SHP-2-expressing cells but did not increase it further. However, in contrast to WT SHP-2-expressing cells, their calcium signal spread was not affected by NO (E76A-con: 96±11%; E76A-NO: 98±9%). These data indicate that SHP-2 is essential for NO-induced regulation of Cx37-containing GJ. In all analyzed HUVEC Consistent with these observations, cell lysates from HUVEC expressing WT SHP-2 reduced the phosphorylation of the Cx37-phosphopeptide. In contrast, the phosphorylation of the Cx37-phosphopeptide remained high on NO treatment of WT SHP-2-expressing HUVEC (ratio of dephosphorylated/phosphorylated is reduced in the presence of NO: WT SHP-2 con: 0.25±0.05; WT SHP-2 NO: 0.11±0.02; Figure 5B ). Cell lysates from HUVEC expressing the inactive form of SHP-2 (CS) did not dephosphorylate the Cx-phosphopeptide independent of the presence of NO (CS con: 0.08±0.03; CS NO: 0.11±0.02; Figure 5B ). Lysates from HUVEC expressing the constitutively active SHP-2 (E76A) elicited a similar dephosphorylation rate as lysates from WT SHP-2 cells (E76A-con: 0.22±0.01; Figure 5B ), which was, however, not reduced by pretreatment with NO (E76A-NO: 0.19±0.02).
NO Redirects the Spread of the Calcium Signal to the Endothelium of Isolated Arterial Microvessels
To study whether the NO-dependent regulation of GJ controls the spread of calcium signals across MEGJ, we analyzed the calcium signal propagation from a single mechanically stimulated EC to its neighboring EC as well as to the underlying SMCs in the presence or absence of NO (2 µmol/L SNAP) in freshly isolated segments of small murine skeletal muscle arteries.
Representative ratio images of EC ( Figure 6A , left) show that the calcium signal spreading within EC was enhanced by ≈65% after NO treatment in comparison to control conditions ( Figure 6B ; EC: con: 100±13%; NO: 166±10%). Similarly, SHP-2 inhibition by PTPI IV caused a significant increase in the spread of the calcium signal by ≈70% (n=10-14; 4 
NO Increases the Endothelial Calcium Response and the Resulting (EDH-Mediated) ACh-Dependent Vessel Dilation
Having observed that NO affects the spread of calcium from EC to SMC, we next investigated whether this affects the physiological response and, therefore, measured the vasodilaton of microvessels. Isolated cannulated small murine skeletal muscle arteries, prepared as described previously, 20, 21 were preconstricted with 1 µmol/L norepinephrine in the presence of indomethacin. Dilation was induced by successive addition of 30 and 300 nmol/L ACh and NO (30 µmol/L SNAP), and relative diameter changes were measured. This protocol was repeated after a 15-minute incubation period with either sham solution or a solution containing NO (10 µmol/L SNAP) and the pharmaceutical soluable guanylyl cyclase inhibitor ODQ (1H- [1, 2, 4] oxadiazolo [4,3-a] quinoxalin-1-one).
As expected, ACh induced a concentration-dependent vasodilation of these vessels and ODQ (10 µmol/L, 15 minutes) virtually blocked the direct dilator action of NO in these vessels (relative dilation: before ODQ: 72±2%; with ODQ: 6±2%; n=3). However, the ACh-induced vasodilator response was significantly augmented after incubation with NO in combination with ODQ compared with incubation with control solution ( Figure 7A ). Simultaneous registration of smooth muscle calcium levels in these vessels showed the typical calcium decrease attributable to ACh stimulation under control conditions, which we had previously shown to be dependent on EDH. 22 This calcium decrease was further enhanced in the presence of NO and ODQ ( Figure 7B ). In a separate set of experiments, the calcium increase in response to ACh was studied in EC in the same type of vessels, which were cut open to obtain better optical access to the endothelium. In these vessels, incubation with NO (and ODQ) resulted in a significantly higher endothelial calcium increase in response to ACh than that observed under control conditions ( Figure 7C) . Importantly, incubation with ODQ alone (10 µmol/L ODQ; [A] ) in which the tyrosine residue was phosphorylated. B, The sum of all peaks representing dephosphorylation (gray arrows) increased, when incubated with HEPES-treated control lysates of HeLa cells expressing Cx37-GFP (con), whereas the sum of phosphorylated peaks (black arrows) decreased. C, NO treatment significantly prevented dephosphorylation of the Cx37-phosphopeptide. D, Quantification of the dephosphorylated/phosphorylated ratio (de-phos/phos) from all experiments. Treatment with the tyrosine phosphatase inhibitor orthovanadate (OV) or the specific SHP-2 blockers PTPI IV (protein tyrosine phosphatase inhibitor IV) and PTPI XXXI (protein tyrosine phosphatase inhibitor XXXI) showed similar protective effects comparable to NO treatment (n=4-15 cultures, *P<0.05, ANOVA, Bonferroni vs non-NO). E, Finally, incubation of the phosphopeptide with lysates from human umbilical vein endothelial cells (HUVECs) also led to dephosphorylation of the peptide, which was blocked by NO (n=5 cultures,*P<0.05, t test).
15 minutes) did not affect the calcium changes in EC (before ODQ: 30 nmol/L ACh: 42±18%, 300 nmol/L ACh: 100±0%; after ODQ: 30 nmol/L ACh: 32±8%; 300 nmol/L ACh: 80±11%; n=4; 3 animals).
Discussion
Our study shows that the inhibitory effect of NO on intercellular calcium communication via Cx37-containing GJ 15 is dependent on the phosphorylation state of a single tyrosine residue in the far end of the C-terminus of Cx37. NO exerts its effect not directly on Cx37 but rather by inhibiting the activity of the tyrosine phosphatase SHP-2. By binding to phosphorylated tyrosines with its SH-2 domains, SHP-2 is rendered active by the resulting conformational change and can, thus, dephosphorylate its target. 23 The physical interaction of SHP-2 with Cx37, therefore, suggests that Cx37 is indeed a specific target of SHP-2. Because we 15 and others 24 have shown before that Cx37 is highly expressed in MEGJ, functional effects may be expected to occur there. Indeed, we observed that the spread of an endothelium-derived calcium signal to the underlying smooth muscle is reduced by NO. At the same time, the intercellular spread of calcium signals via endothelial GJ-where NO has not such an inhibitory function because of compensation by Cx43 15 -is enhanced. Both effects have the potential to augment the response of the endothelium to calcium-increasing vasoactive dilators, as shown here for ACh. We, therefore, propose a novel role of NO in arterial microvessels beyond its known direct vasodilator action on smooth muscle in larger vessels, 25 especially because NO has been shown to be of minor importance as a direct vasodilator in the microcirculation. 10 Instead, we would like to suggest that NO may be effective at the level of the endothelium whereby it augments EDH-dependent dilation mainly by blocking endothelial calcium loss via MEGJ. As long as the endothelium produces sufficient amounts of endogenous NO, additional NO donors may not further add to this effect because of the lack of a direct vasodilator action on SMC. Microvascular impairment such as that observed in diabetic microangiopathy or in vascular remodeling during chronic hypertension may (by reactive oxygen species-dependent mechanisms) critically reduce NO levels, which then also reduces EDH responses. This phenomenon may indeed contribute to the endothelial microvascular impairment observed in these diseases but cannot explain any impairment of endothelial vasomotor function in larger vessels, which generally lack myoendothelial junctions. It is, however, not yet clear whether the proposed mechanism can be generalized for all microvascular beds and EDH stimulators, for example, ACh versus bradykinin, the latter eliciting different effects with regard to EDH. 28 Studies in the canine epicardial microcirculation showed an inhibitory rather than an augmenting influence of NO on bradykinininduced, EDH-mediated dilation. 28 This inhibitory effect was explained by NO reducing the activity of Cyt-P450 monooxygenase, which is known to be the enzymatic source of epoxyeicosatrienoic acids (EETs). EETs have been shown to act as EDH in many vascular beds including small resistance arteries 29, 30 and large coronary arteries. 31, 32 Likewise, in small mouse mesenteric vessels, NO was shown to reduce H 2 S-mediated EDH by inhibiting one of the major H 2 Sproducing enzymes cystathionine-γ-lyase. 33 We have not identified the EDH acting in the small vessels studied here, but it may be potassium released by Ca 2+ -dependent activation of IK Ca and SK Ca , as first reported by Edwards et al 34 and recently reviewed in the study by Garland and Dora. 35 This EDH would not require an (NO-sensitive) enzymatic system and hence would not be inhibited by NO. Of note, NO may reduce EDH not only by inhibiting enzymes but also by reducing the endothelial Ca 2+ increase as shown by Bauersachs et al 36 in HUVEC (lacking myoendothelial junctions) in response to bradykinin. In intact microvessels containing myoendothelial junctions, we can exclude this effect of NO. In agreement with our findings, NO was shown to augment TRPV4 (transient receptor potential cation channel subfamily V member 4)-mediated EDH responses in the rat pulmonary artery. 37 It is interesting to note that TRPV4 is also expressed next to MEGJ. 35 To achieve defined conditions, we blocked the endogenous NO synthesis by Nω-nitro-l-arginine and exposed the cells to controlled concentrations of the exogenously applied NO donor SNAP. Samouilov and Zweier 38 showed that the SNAP concentration correlates well with the NO released by SNAP. In our experiments, we used 2 µmol/L SNAP leading to a concentration, which is comparable to the NO concentration (sum of nitrite and nitrate concentration) measured in the medium of HUVEC after stimulation with 10 µmol/L histamine. 39 This is in accordance with the model of Laurent et al, 40 who predicted a maximum of 4 to 5 µmol/L NO close to the NO-producing cell layer (NO production was induced by addition of l-arginine). We, therefore, suggest that the NO-dependent effect, which we describe here, is at least relevant in stimulated EC. We have, however, not tested whether the NO concentrations achieved in resting EC may already exert some influence on gap junctional transfer because cultured cells are supposed to synthesize less NO because of the lack of shear stress. Moreover, our calculation does not account for the potential role of the localization of NO synthase for NO concentrations near GJ, which has been shown to be located in conjunction with hemoglobin α in myoendothelial contact areas.
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NO regulates GJIC in several cells types and experimental models. 12, 13, 41 A direct effect of NO on connexins is described for Cx43, which can be S-nitrosylated at cysteine 271, 12 leading to an increased permeability of GJ containing Cx43. This nitrosylation is reversed by the S-nitrosoglutathione, whose intracellular location is closely associated with GJ spots. 12 Because the last 14 amino acids of Cx37, which are essential for the NO effect, do not contain a cysteine residue, S-nitrosylation is unlikely to mediate the NO effect on Cx37.
Cx37 is expressed in various tissues, [42] [43] [44] but the effect of NO on Cx37 may be of highest importance in the vasculature. This is because of the fact that Cx37 is highly expressed in myoendothelial junctions, 15, 24 where it contributes to the control of myoendothelial signal exchange, 15 which plays a role predominantly in microvessels.
We could previously show that the NO effect on Cx37 functionality dominates in heterotypic GJ (containing Cx43 and Cx37).
14 Therefore, an effect of NO on Cx43 nitrosylation in MEGJ, as described by Straub et al, 12 is less likely to control the function of MEGJ when they, at least partly, are formed by Cx37. Of note, a tyrosine residue at the second to last position can be found in at least 3 other connexins, which are preferentially expressed in the nervous system and probably NO sensitive: Cx33, 45, 46 Cx35, 47, 48 and Cx36. 49, 50 Unfortunately, in none of the studies it was analyzed whether NO affects the phosphorylation of the tyrosine residues similarly as described here. Phosphorylation is a frequent post-translational modification of connexins that can both increase and decrease GJ permeability. 51 Several serine/threonine kinases like PKA (protein kinase A), CamKII (Ca 2+ /calmodulin-dependent protein kinase II), and Akt (protein kinase B) are known to increase GJIC, [52] [53] [54] whereas others like PKC (protein kinase C), PKG (protein kinase G), and MAPK (mitogen-activated protein kinase) 48, 52, 55 or the proto-oncogene tyrosine-protein kinase Src can decrease the permeability of GJ. [56] [57] [58] [59] The receptor protein tyrosine phosphatase µ interacts with the C-terminus of Cx43 58, 60 and probably counteracts the negative regulation of Cx43 by Src. 55, 57 We do not yet know which tyrosine kinase(s) may be responsible for the phosphorylation of tyrosine 332 in Cx37. However, because NO prevents the dephosphorylation, we propose that the responsible tyrosine kinase induces a high level of Y332 phosphorylation under resting conditions.
We identified SHP-2 as a significant link for the NO effect. It is already known that NO can modify SHP-2 via S-nitrosylation of the critical cysteine residue in its catalytic pocket, leading to its inactivation, 19, 61 which is in accordance to our own findings. Because phosphatases obtain their substrate specificity mainly by their location within the cell, 62 it is, therefore, important that we could identify a novel, physical interaction between Cx37 and SHP-2, which may allow tight control of the phosphorylation status of Y332 in the C-terminus of Cx37. Consistent with this conclusion, specific inhibitors of SHP-2 ( Figure 3 ) mimicked the NO effect. Likewise, expression of a nonfunctional form of SHP-2 (CS; Figure 5 ) showed the same effects as NO.
Our experiments on isolated small arteries suggest that the observed NO effect may have functional implications in microvessels with regard to the signaling role of calcium. Both interendothelial GJ and MEGJ seem to be important. A stimulation of the endothelium by agonists or increased shear stress typically leads to an increase of the intracellular calcium, which activates enzymatic pathways leading to endothelial vasodilator synthesis. 63 Endothelial GJ have been shown by us to be necessary to enable full activation of the endothelium by vasoactive agonists such as histamine or ATP. 1 MEGJ are supposed to have an important gatekeeper role in view of the different effects of calcium in smooth muscle and endothelium with regard to the control of vascular tone. Any loss of endothelial calcium toward SMC may lead to a shortened or even reduced endothelial activation. This effect can be clearly counteracted by the inhibitory action of NO on myoendothelial calcium signal transfer. Indeed, NO reduced the spreading of calcium signals to SMC in microvessels and, at the same time, enhanced the calcium signal spreading in the endothelium in the isolated vessels. Furthermore, vessel dilation mediated via EDH (induced by ACh) was increased in the presence of NO resulting in a stronger vasodilator response. The observation of augmented calcium decreases in SMC and increases in EC, respectively, in the presence of NO demonstrate strong uncoupling of EC and SMC with respect to calcium. Of note, we have demonstrated before that NO does not affect electric coupling via Cx37, 14 implying that the uncoupling is not supposed to reduce EDH-mediated effects via GJ.
Our findings, at a first glance, seem to be at variance to earlier findings by Dora et al 64 and Dora and Garland 65 who found that calcium or IP 3 (inositol trisphosphate) from activated SMC were diffusing via MEGJ to EC thereby inducing an NO-dependent negative feedback inhibition. Whereas it remains unclear whether a calcium transfer would also have taken place after primary endothelial stimulation (as studied here), both observations could be easily reconciled if they occurred on different time points after primary smooth muscle stimulation: any increase in endothelial calcium from smooth muscle sources would secondarily start the NO-dependent inhibition of further myoendothelial calcium transfer, thus further augmenting endothelial activation and feedback control.
In summary, we characterized the regulatory site by which NO controls the calcium signal propagation through Cx37-containing GJ. We furthermore identified the tyrosine phosphatase SHP-2 as the essential mediator and NO target. This modulation seems to be most important within small arterial vessels because they express MEGJ enriched of Cx37. In these vessels, the NO-dependent inhibition of calcium signal propagation is supposed to increase the overall endothelial sensitivity to agonists by augmenting the calcium signal within the endothelium. Thus, this must be considered a novel mechanism by which microvascular endothelial function can be controlled. Finally, an impairment of this mechanism may, thus, contribute to the development of microvascular diseases.
